Heron Therapeuti (HRTX)

Collard Craig A 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Jan 19, 2026 | Filing ID: 016413

Register to leave comments

  • News bot Jan. 29, 2026, 2:22 p.m.

    🔍 Collard Craig A (Executive)

    Company: HERON THERAPEUTICS, INC. /DE/ (HRTX)

    Report Date: 2026-01-19

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 13,797
    • Total shares sold: 13,797

    Detailed Transactions and Holdings:

    • Acquired 13,797 shares of Common Stock (Direct)
      Date: 2026-01-19 | Code: M | equity_swap_involved: false | shares_owned_after: 536,921.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 13,797 shares of Restricted Stock Units (Derivative)
      Date: 2026-01-19 | Code: M | equity_swap_involved: false | shares_owned_after: 110,375.00 | transaction_form_type: 4 | Footnotes: F2, F2

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
    • F2: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).